Skip to main content
. 2017 Oct 10;38(6):3327–3334. doi: 10.3892/or.2017.6019

Figure 2.

Figure 2.

The survival curve of glioma patients analyzed according to the expression of BAF53a. (A) Results showed that glioma patients in the high BAF53a expression group had poorer overall survival than those in the low BAF53a expression group. (B) Glioma patients in the high BAF53a expression group had poorer progression-free survival than those in the low BAF53a expression group.